Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist

Preventing osteoporotic fractures is an issue requiring urgent attention to reduce mortality. However, unlike chronic kidney disease-mineral and bone disorder (CKD-MBD), osteoporosis is inadequately addressed in patients undergoing chronic dialysis. In fact, little is known about the proper use of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Masatomo, Ushimaru, Shu, Fujishima, Rie, Sumi, Hirofumi, Shiizaki, Kazuhiro, Tominaga, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685381/
https://www.ncbi.nlm.nih.gov/pubmed/36438716
http://dx.doi.org/10.1016/j.bonr.2022.101639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685381/
https://www.ncbi.nlm.nih.gov/pubmed/36438716
http://dx.doi.org/10.1016/j.bonr.2022.101639

Ejemplares similares